Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin.
Washington State University scientists have uncovered a method to interfere with a key viral protein, stopping viruses from getting inside cells where they can cause disease. The discovery points toward a possible new strategy for developing antiviral treatments in the future.
The work, published in the journal Nanoscale, involved researchers from the School of Mechanical and Materials Engineering and the Department of Veterinary Microbiology and Pathology. Together, they identified and disrupted a specific molecular interaction that herpes viruses depend on to enter cells.
"Viruses are very smart," said Jin Liu, corresponding author of the study and a professor in the School of Mechanical and Materials Engineering. "The whole process of invading cells is very complex, and there are a lot of interactions. Not all of the interactions are equally important — most of them may just be background noise, but there are some critical interactions."
Targeting the Protein Viruses Use to Break In
The researchers focused on a viral "fusion" protein, which herpes viruses use to attach to cells and merge with them, triggering infection and disease. Scientists still lack a clear understanding of how this large and complicated protein changes shape to allow viruses inside cells. This limited knowledge is one reason vaccines for many common herpes viruses have remained elusive.

How AI Narrowed Down Thousands of Possibilities
To tackle this challenge, the team turned to artificial intelligence and molecular scale simulations. Professors Prashanta Dutta and Jin Liu analyzed thousands of possible interactions within the fusion protein to find a single amino acid that plays a central role in viral entry. They designed an algorithm to examine interactions among amino acids, the basic building blocks of proteins, and then applied machine learning to sort through the data and identify which interactions mattered most.
A Single Mutation That Blocks Infection
Once the key amino acid was identified, laboratory experiments led by Anthony Nicola from the Department of Veterinary Microbiology and Pathology put the findings to the test. By altering that one amino acid, the researchers found that the virus could no longer successfully fuse with cells. As a result, the herpes virus was effectively prevented from entering the cells.
According to Liu, the computational work was essential because testing even one interaction in the lab can take months. Narrowing the focus ahead of time made the experimental phase far more efficient.
"It was just a single interaction from thousands of interactions. If we don't do the simulation and instead did this work by trial and error, it could have taken years to find," said Liu. "The combination of theoretical computational work with the experiments is so efficient and can accelerate the discovery of these important biological interactions."
What Scientists Still Need to Understand
Although the team confirmed the importance of this specific interaction, many questions remain about how changing one amino acid affects the structure of the entire fusion protein. The researchers plan to continue using simulations and machine learning to better understand how small molecular changes influence the protein at larger scales.
"There is a gap between what the experimentalists see and what we can see in the simulation," said Liu. "The next step is how this small interaction affects the structural change at larger scales. That is also very challenging for us."
Reference: "Modulation of specific interactions within a viral fusion protein predicted from machine learning blocks membrane fusion" by Ryan E. Odstrcil, Albina O. Makio, McKenna A. Hull, Prashanta Dutta, Anthony V. Nicola and Jin Liu, 4 November 2025, Nanoscale.
DOI: 10.1039/D5NR03235K
In addition to Liu, Dutta and Nicola, the project was conducted by PhD students Ryan Odstrcil, Albina Makio, and McKenna Hull. The work was funded by the National Institutes of Health.
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]















